GRAIL Q2 Revenue Jumps 26% on 35% Galleri Volume Surge; Samsung Deal Closes, Adding $110M
GRAL has more than doubled off its 52-week low of $29.95 on elevated volume (2.8× avg).
Summary
GRAIL's Q2 revenue rose 26% to $44.7M on 35% Galleri volume growth. The $110M Samsung investment closed at a premium, but a $25.4M impairment and new lawsuits cloud the outlook.
Key Events · Earnings and Guidance · GRAL
-
Q2 Revenue Surges 26%
Total revenue hit $44.7M, up from $35.5M a year ago, driven by a 35% increase in Galleri test volume to over 117,000 tests in H1 2026.
-
Samsung Strategic Investment Closes
Completed $110M private placement at $70.05/share (a premium to today's $64.97), issuing 1.57M shares. Proceeds fund commercialization and working capital.
-
$25.4M Impairment on Samsung Deferred Asset
The full deferred asset from the Samsung deal was written off as unrecoverable under the collaboration agreement, hitting Q2 earnings.
-
New Securities Class Action Filed
A putative class action (Robbins v. GRAIL) alleges misleading statements about the NHS-Galleri trial. A related derivative suit (Augitto) was also filed.
Analysis · GRAL · Industrial Applications And Services
GRAIL delivered strong Q2 results with revenue up 26% to $44.7M, driven by a 35% jump in Galleri test volume following positive NHS-Galleri and PATHFINDER 2 data. The company closed its $110M Samsung strategic investment, adding 1.57M shares at $70.05 — a premium to the current $64.97 stock price — and extended its cash runway. However, a $25.4M impairment on the Samsung deferred asset and new securities class actions tied to the NHS-Galleri trial add risk. The combination of accelerating commercial traction, a major strategic partnership, and litigation overhang makes this a pivotal update for investors.
At the time of this filing, GRAL was trading at $64.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $29.95 to $118.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.